Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/14/21 → 3/20/24 |
Funding
- Fortrea Incorporated: $28,925.00
A Phase 2 Study of BA3011 Alone and in Combination With PD-1 Inhibitor in Adult Patients With Metastatic Non-small Cell Lung Cancer (NSCLC) Who Had Prior Disease Progression on a PD-1/L-1 Inhibitor
- Arnold, Susanne (PI)